Global Innovative Platforms Inc.

Global Innovative Platforms Inc. is a medical technology company focused on advancing animal health through breath analysis and air quality technology. The company develops non-invasive diagnostic tools for detecting diseases and assessing treatment effectiveness in animals. Its proprietary technologies, "VOCAM Plus" and the "FROG," utilize advanced gas chromatography and A.I. software to provide rapid and accurate breath and air analysis. These technologies are designed to detect Volatile Organic Compounds (VOCs) that indicate the presence of diseases and conditions, forming what the company refers to as "breath prints." Global Innovative Platforms applies Machine Learning technologies (Artificial Intelligence) to detect these patterns. The company's mission is to revolutionize the early detection of a wide array of animal-related abnormalities, including disease, treatment effectiveness, and potentially toxic environmental and food conditions. Global Innovative Platforms has identified several opportunities and is prioritizing the development of a breath test to detect heartworm in dogs. The company believes this same test can also be utilized to identify response to therapy. Its licensed rights include all animal-related applications. The current leading heartworm test, antigen detection with a blood sample, typically requires the heartworm itself to be approximately six months old to be detected.